BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1352178)

  • 1. Jaw muscle activity, the nucleus accumbens, and dopaminergic agonists: a new approach.
    Prinssen EP; Koene P; Heeren D; Cools AR
    Brain Res Bull; 1992 May; 28(5):775-80. PubMed ID: 1352178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG
    Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats.
    Wahnschaffe U; Löscher W
    Brain Res; 1991 Jul; 553(2):181-7. PubMed ID: 1681980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
    Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
    Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
    Liang RZ; Wu M; Yim CC; Mogenson GJ
    Brain Res; 1991 Jul; 554(1-2):85-94. PubMed ID: 1681991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W; Neill DB; Lynn M; Justice JB
    Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.
    Wu M; Brudzynski SM; Mogenson GJ
    Brain Res Bull; 1993; 32(4):395-8. PubMed ID: 8106125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioural satiety sequence.
    Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1995 Jan; 117(1):82-90. PubMed ID: 7724706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE; Woolverton WL
    Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: an electrophysiological and behavioural study.
    Yang CR; Mogenson GJ
    Neuroscience; 1987 Dec; 23(3):1041-55. PubMed ID: 2963972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity.
    Plaznik A; Stefanski R; Kostowski W
    Psychopharmacology (Berl); 1989; 99(4):558-62. PubMed ID: 2594923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
    Messier C; Mrabet O; Destrade C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):177-82. PubMed ID: 1347172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional potentiation between D1 and D2 dopamine agonists: effects of unilateral intra-accumbens injections on locomotor activity in mice.
    Messier C; Mrabet O; Durkin TP; Destrade C
    Life Sci; 1991; 49(9):PL43-8. PubMed ID: 1678133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.